PB 40 of 2023
National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 3)
I, Nikolai Tsyganov, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination.
Dated 26 April 2023
NIKOLAI TSYGANOV
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
Contents
2 Commencement
3 Authority
4 Schedules
Schedule 1—Amendments
National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)
This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2023 (No. 3).
This instrument may also be cited as PB 40 of 2023.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 May 2023 |
|
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under section 85B of the National Health Act 1953.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)
Omit
Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | Natrilix SR | 90 | 7.17 | 13.82 | |
| Tablet containing indapamide hemihydrate 2.5 mg | Oral | Natrilix | 90 | 4.91 | 11.96 |
Insert
Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | Natrilix SR | 90 | 7.17 | 13.82 |
3. Schedule 1 - omit entry for Norethisterone with ethinylestradiol